Harnessing microRNA biology to treat
cardiovascular and muscle disease
Thursday May 17, 2012
Home
About Us
Our Mission and Vision
Founders
Board of Directors
Leadership
Scientific Advisory Board
Investors
Partnerships
Pipeline
Research
What are miRNAs?
Technology Development
Areas of Focus
Heart Disease
Vascular Disorders
Skeletal Muscle Disease
Myeloproliferative Diseases
Olson Laboratory
Publications
Intellectual Property
Glossary of Terms
News
Partnerships
Strategic Alliances
Academic Collaborations
Careers
miRagen Culture
Benefits
Job Postings
Contact Us
Eur J Heart Failure, 2012
Circulating microRNAs to identify human heart failure
Seto, AG and van Rooij, E
miRagen Therapeutics Inc., 6200 Lookout Road, Boulder, CO 80301, USA
http://www.ncbi.nlm.nih.gov/pubmed/22253452